Dosimetry of Chimeric TNT in Lung Cancer Patients

S. L. Chen,X. F. Chen,Y. S. Gu,W. G. Liu,Y. C. Chen,B. L. Li

DOI: https://doi.org/10.3760/cma.j.issn.2095-2848.2004.02.014

2004-01-01

Abstract:Objective To assess the irradiated absorbtive dose of tumor and main critical organs chimeric tumor necrotic treatment (chTNT). Methods In 9 lung cancer patients a single intravenous dose of 131 I-chTNT (29.6±3.7) MBq/kg was administered. Blood samples were drawn at different time intervals and urine was collected for up to one week. Tissue distribution was followed for up to one week by gamma camera imaging. The geometric mean of the anterior and posterior counts was obtained from selected regions of interest (ROIs) to determine activity within the critical organs after being subtracted the background activity. Counts from thyroid were obtained from anterior images only. A background region was drawn below the thyroid gland to subtract underlying activity in the neck blood vessels. The geometric mean of the counts in the whole body scintigram at 0.5 h after injection was corrected for radioactive decay from the time of injection,this value being taken as 100%ID. The residence times for each critical organ and the remainder of the body were computed by dividing the area under their %ID/h curves by the 100%ID value. Absorbed doses to the whole body and to normal organ were computed from the residence time according to the MIRD scheme using Mirdose-3 software. Absorbed doses to tumor tissues were estimated using the same approach taken for normal organs. S-factors for tumors were estimated by comparison with normal organs of similar mass and position in the body. Results Mean serum disappearance half time values for 131 I-chTNT were α (4.9±9.4) h,β (61.7±21.2) h;and whole body,(99±10)h. Mean urine biological clearance half time values was (90±10) h. The absorbed dose of tumor was (8.28±2.65) Gy,the tumor-to-nontumor ratio was 3.95±1.55,while the absorbed dose of marrow was 0.44～0.73 Gy,thyroid was 0 47～23.09 Gy,ovaries was 0.50～0.77 Gy,testicles was 0.38～0.58 Gy,kidneys was 1.71～4.55 Gy,liver was 1.18～2.63 Gy,and lungs was 1.55～2.74 Gy. Conclusions Single intravenous dose of 131 I-chTNT could hardly depress the growth of tumor masses. Repeated intravenous 131 I-chTNT is needed for its depression.